 of ramipril on walking performance (Section 4B).
Antiplatelet and antithrombotic agents. Numerous
studies have demonstrated the beneÔ¨Åt of antiplatelet therapy,
especially aspirin, in doses of 75 to 325 mg/d in reducing
rates of myocardial infarction, stroke, and vascular-related
deaths in individuals with symptomatic lower extremity
atherosclerosis.81 The American Heart Association practice
guidelines for